FTSE All-Share
5.329,48
PKT
+28,09
PKT
+0,53
%
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 14.06.12 | BP outperform | Credit Suisse Group | |
| 14.06.12 | BT Group neutral | J.P. Morgan Cazenove | |
| 14.06.12 | Sky overweight | J.P. Morgan Cazenove | |
| 14.06.12 | Shell (ex Royal Dutch Shell) neutral | Credit Suisse Group | |
| 13.06.12 | Wm Morrison Supermarkets neutral | HSBC | |
| 13.06.12 | Sky neutral | UBS AG | |
| 13.06.12 | HSBC outperform | Credit Suisse Group | |
| 13.06.12 | Standard Chartered neutral | Credit Suisse Group | |
| 13.06.12 | Shell (ex Royal Dutch Shell) neutral | Credit Suisse Group | |
| 12.06.12 | HSBC overweight | Morgan Stanley | |
| 12.06.12 | Glencore outperform | Cheuvreux SA | |
| 11.06.12 | Sky equal-weight | Barclays Capital | |
| 11.06.12 | Rio Tinto buy | Goldman Sachs Group Inc. | |
| 11.06.12 | GSK buy | Société Générale Group S.A. (SG) | |
| 11.06.12 | AstraZeneca neutral | J.P. Morgan Cazenove | |
| 11.06.12 | BP outperform | Credit Suisse Group | |
| 08.06.12 | AstraZeneca buy | UBS AG | |
| 08.06.12 | Sky overweight | J.P. Morgan Cazenove | |
| 08.06.12 | GSK buy | Citigroup Corp. | |
| 08.06.12 | Vodafone Group sell | Société Générale Group S.A. (SG) | |
| 08.06.12 | Standard Chartered buy | Sarasin Research | |
| 08.06.12 | BT Group buy | Nomura | |
| 08.06.12 | BP outperform | RBC Capital Markets | |
| 08.06.12 | BP buy | Deutsche Bank AG | |
| 07.06.12 | GSK buy | Société Générale Group S.A. (SG) | |
| 07.06.12 | Tullow Oil hold | Société Générale Group S.A. (SG) | |
| 07.06.12 | Diageo hold | ING | |
| 06.06.12 | BP buy | UBS AG | |
| 06.06.12 | J. Sainsbury buy | UBS AG | |
| 06.06.12 | Imperial Brands buy | UBS AG | |
| 06.06.12 | BP neutral | Citigroup Corp. | |
| 06.06.12 | BP hold | Société Générale Group S.A. (SG) | |
| 06.06.12 | BP overweight | J.P. Morgan Cazenove | |
| 05.06.12 | Shell (ex Royal Dutch Shell) halten | Independent Research GmbH | |
| 05.06.12 | BP neutral | Citigroup Corp. | |
| 05.06.12 | AstraZeneca underperform | Credit Suisse Group | |
| 05.06.12 | GSK neutral | Credit Suisse Group | |
| 05.06.12 | Shell (ex Royal Dutch Shell) neutral | Citigroup Corp. | |
| 04.06.12 | Prudential outperform | RBC Capital Markets | |
| 04.06.12 | Diageo neutral | Exane-BNP Paribas SA |